CNTEClinical Trials•businesswire•
ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients
Sentiment:Positive (80)
Summary
SAN DIEGO--(BUSINESS WIRE)-- #5hmC--ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect Pancreatic Cancer Test.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 16, 2025 by businesswire